Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating lactoferrin and lysozyme supplementation to address long-term diarrhea sequelae in children; recruitment is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactoferrin (lactoferrin)
  • Lysozyme (lysozyme)

Snippet

Sponsor: University of Washington | Conditions: Diarrhea, Wasting | Phase 3 | Status: RECRUITING